Citation Tools

Download PDFPDF
SHOULD CA125 RESPONSE CRITERIA BE PREFERRED TO WHO CRITERIA IN THE MONITORING OF SECOND-LINE CHEMOTHERAPY (SLC) OF EPITHELIAL OVARIAN CARCINOMA (EOC)?

Download to a citation manager

Cite this article as:
Gronlund B, Hansen HH, Engelholm SA, et al
SHOULD CA125 RESPONSE CRITERIA BE PREFERRED TO WHO CRITERIA IN THE MONITORING OF SECOND-LINE CHEMOTHERAPY (SLC) OF EPITHELIAL OVARIAN CARCINOMA (EOC)?